NCT00602381View on ClinicalTrials.gov

Bioequivalency Study of 450 mg Lithium Carbonate Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

November 30, 2002

Study Completion Date

November 30, 2002

Conditions
Bipolar Disorder
Interventions
DRUG

Lithium

Trial Locations (1)

72202

Arkansas Research, Little Rock

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00602381 - Bioequivalency Study of 450 mg Lithium Carbonate Under Fasting Conditions | Biotech Hunter | Biotech Hunter